Literature DB >> 5795799

Relationship of pentazocine plasma levels to pharmacological activity in man.

B A Berkowitz, J H Asling, S M Shnider, E L Way.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5795799     DOI: 10.1002/cpt1969103320

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  16 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Human sleep during chronic morphine intoxication.

Authors:  D C Kay
Journal:  Psychopharmacologia       Date:  1975-10-31

3.  Effects of pentazocine on cardiac function.

Authors:  T N Appleyard
Journal:  Proc R Soc Med       Date:  1975-12

4.  [Not Available].

Authors:  J Radke; E Turner; D Kettler
Journal:  Schmerz       Date:  1990-12       Impact factor: 1.107

5.  The influence of smoking on the intersubject variation in pentazocine elimination.

Authors:  D P Vaughan; A H Beckett; D S Robbie
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

Review 6.  Pentazocine: a review of its pharmacological properties, therapeutic efficacy and dependence liability.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

7.  Editorial: Mental side effects of pentazocine.

Authors: 
Journal:  Br Med J       Date:  1974-02-23

8.  The clinical pharmacology of pentazocine.

Authors:  J P Payne
Journal:  Drugs       Date:  1973       Impact factor: 9.546

Review 9.  Protein binding and kinetics of drugs in liver diseases.

Authors:  T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

Review 10.  Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children.

Authors:  K T Olkkola; K Hamunen; E L Maunuksela
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.